Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
説明 | Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes. |
別名 | SP 2086 |
分子量 | 562.36 |
分子式 | C19H21F6N4O7P |
CAS No. | 1256756-88-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: ≥ 150 mg/mL (266.73 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Retagliptin Phosphate 1256756-88-3 Proteases/Proteasome Ubiquitination DPP-4 Proteasome SP 2086 SP2086 inhibit GLP-1 T2DM SP-2086 Retagliptin DPP Inhibitor Dipeptidyl Peptidase inhibitor